HUP0102507A2 - Paroxetin alkalmazása a dohányzás abbahagyásának elősegítésére, illetve a visszaeső dohányzás csökkentésére vagy megelőzésére szolgáló gyógyszerkészítmények előállítására - Google Patents

Paroxetin alkalmazása a dohányzás abbahagyásának elősegítésére, illetve a visszaeső dohányzás csökkentésére vagy megelőzésére szolgáló gyógyszerkészítmények előállítására

Info

Publication number
HUP0102507A2
HUP0102507A2 HU0102507A HUP0102507A HUP0102507A2 HU P0102507 A2 HUP0102507 A2 HU P0102507A2 HU 0102507 A HU0102507 A HU 0102507A HU P0102507 A HUP0102507 A HU P0102507A HU P0102507 A2 HUP0102507 A2 HU P0102507A2
Authority
HU
Hungary
Prior art keywords
paroxetine
smoking
medicament
manufacture
reduction
Prior art date
Application number
HU0102507A
Other languages
English (en)
Inventor
Martin X. Steiner
Original Assignee
Smithkline Beecham Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp. filed Critical Smithkline Beecham Corp.
Publication of HUP0102507A2 publication Critical patent/HUP0102507A2/hu
Publication of HUP0102507A3 publication Critical patent/HUP0102507A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Addiction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány a dohányzás abbahagyásának elősegítésére, illetve avisszaeső dohányzás csökkentésére vagy megelőzésére szolgáló eljárásravonatkozik, amelynek során egy ezt igénylő embernek hatásos,nemtoxikus mennyiségben paroxetint vagy egy gyógyászatilag elfogadhatóparoxetin sót vagy szolvátot adnak be. A találmány további tárgyátképezi a paroxetinnek vagy gyógyászatilag elfogadható sóinak vagyszolvátjainak az alkalmazása a dohányzás abbahagyásának elősegítésére,illetve a visszaeső dohányzás csökkentésére vagy megelőzésére szolgálógyógyszerkészítmények előállítására. Ó
HU0102507A 1998-06-16 1999-06-16 Use of paroxetine in manufacture of a medicament for use in promoting smoking cessation or reduction or preventing smoking HUP0102507A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9812941.4A GB9812941D0 (en) 1998-06-16 1998-06-16 Method of treatment

Publications (2)

Publication Number Publication Date
HUP0102507A2 true HUP0102507A2 (hu) 2002-05-29
HUP0102507A3 HUP0102507A3 (en) 2003-12-29

Family

ID=10833832

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102507A HUP0102507A3 (en) 1998-06-16 1999-06-16 Use of paroxetine in manufacture of a medicament for use in promoting smoking cessation or reduction or preventing smoking

Country Status (20)

Country Link
EP (1) EP1087766A4 (hu)
JP (1) JP2002518330A (hu)
KR (1) KR20010052895A (hu)
CN (1) CN1305379A (hu)
AP (1) AP2000002002A0 (hu)
AU (1) AU740749B2 (hu)
BG (1) BG105127A (hu)
BR (1) BR9911150A (hu)
CA (1) CA2335236A1 (hu)
CZ (1) CZ20004698A3 (hu)
EA (1) EA003584B1 (hu)
GB (1) GB9812941D0 (hu)
HU (1) HUP0102507A3 (hu)
IL (1) IL139943A0 (hu)
NO (1) NO20006383L (hu)
NZ (1) NZ508532A (hu)
PL (1) PL345261A1 (hu)
SK (1) SK19192000A3 (hu)
WO (1) WO1999065491A1 (hu)
ZA (1) ZA200007396B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL154422A0 (en) * 2000-08-28 2003-09-17 Synthon Bv Paroxetine compositions and processes for making the same
WO2003057151A2 (en) 2001-12-28 2003-07-17 Teva Pharmaceutical Industries Ltd. A stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof
US20060039975A1 (en) * 2004-08-20 2006-02-23 Zalman Vilkov Paroxetine formulations
FR2926221A1 (fr) * 2008-01-14 2009-07-17 Tassin Thomas Compositions permettant la reproduction artificielle des conditions pharmacologiques de la dependance aux drogues addictives telles que opiaces, psychostimulants, tabac et alcool, par la combinaison de nicotine et d'un ligand.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
AU658155B2 (en) * 1990-11-24 1995-04-06 Beecham Group Plc Use of paroxetine for the treatment of senile dementia, or anorexia
SK283608B6 (sk) * 1995-02-06 2003-10-07 Smithkline Beecham Plc Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method

Also Published As

Publication number Publication date
NO20006383D0 (no) 2000-12-14
NZ508532A (en) 2003-08-29
IL139943A0 (en) 2002-02-10
BG105127A (en) 2001-11-30
SK19192000A3 (sk) 2001-05-10
JP2002518330A (ja) 2002-06-25
EP1087766A1 (en) 2001-04-04
BR9911150A (pt) 2001-03-06
HUP0102507A3 (en) 2003-12-29
AU4688599A (en) 2000-01-05
NO20006383L (no) 2000-12-14
CA2335236A1 (en) 1999-12-23
WO1999065491A1 (en) 1999-12-23
AU740749B2 (en) 2001-11-15
PL345261A1 (en) 2001-12-03
GB9812941D0 (en) 1998-08-12
CN1305379A (zh) 2001-07-25
EP1087766A4 (en) 2001-11-21
EA003584B1 (ru) 2003-06-26
ZA200007396B (en) 2002-02-27
EA200100041A1 (ru) 2001-06-25
AP2000002002A0 (en) 2000-12-31
CZ20004698A3 (cs) 2002-02-13
KR20010052895A (ko) 2001-06-25

Similar Documents

Publication Publication Date Title
ATE371665T1 (de) Zuckerderivate von hydromorphon, dihydromorphin und dihydroisomorphin, zusammensetzungen davon und verwendung zur vorbeugung und behandlung von schmerzen
IL165264A (en) Protein kinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating protein kinase-associated diseases
ID29181A (id) Kombinasi formoterol dan garam tiotropium
SE9803239D0 (sv) Composition for the treatment of acute pain
HUP0600140A3 (en) Prostaglandine derivatives for the treatment of diseases with bone mass loss having ep4 agonist activity and pharmaceutical compositions thereof
BG105459A (en) Pharmaceutical moxifloxacin preparation
NO20022442D0 (no) Legemidler for sykdommer i forbindelse med reduksjon i benmasse
MY118526A (en) Method for improving the pharmacokinetics of tipranavir
CA2240717A1 (en) Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
NO20024646D0 (no) Kombinasjonsterapier med vaskul¶r-skadende aktivitet
HUP0101404A2 (hu) Fluoxetin-hidroklorid alkalmazása hőhullámok csökkentésére
WO2001041754A8 (en) Inhibitors of collagen-induced platelet aggregation
HK1077215A1 (en) A pharmaceutical composition for treatment of acute myocardial infarction
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
EP1262197A3 (en) Combination treatment for sleep disorders including sleep apnea
MY144781A (en) Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
HUP0102507A2 (hu) Paroxetin alkalmazása a dohányzás abbahagyásának elősegítésére, illetve a visszaeső dohányzás csökkentésére vagy megelőzésére szolgáló gyógyszerkészítmények előállítására
SE9902597D0 (sv) New use
CA2432177A1 (en) Drug for prevention and/or therapy of endometriosis
UA37278C2 (uk) Протикашльова фармацевтична композиція для перорального введення
EP0799618A3 (en) Use of alpha1-adrenoreceptor antagonists in the manufacture of a medicament for the prevention and teatment of cancer
HUP0201629A2 (hu) Eletriptánt és ciklodextrinszármazékot tartalmazó gyógyászati komplex, ezt tartalmazó gyógyszerkészítmény, eljárás az előállítására és alkalmazása
MY134059A (en) Novel use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts
MEP5608A (xx) Nova upotreba (r) – (-)-2-[5-(4-fluorofenil)-3-piridil- metilaminometil] - hromana i njegovih fiziološko prihvatljivi h soli
HUP0402326A2 (hu) Gyógyszerkészítmény addikció megelőzésére fájdalom kezelésében

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees